Toshiba's CT dose tech gets FDA rubber stamp

Justine Varieur Cadet | | Health Imaging | Screening
Toshiba America Medical Systems has received FDA clearance for its Aquilion RXL Edition CT system, which reconstructs images and includes radiation dose reduction technologies.

Aquilion RXL brings radiation dose reduction technology to the 16-detector row CT system with Toshiba’s Adaptive Iterative Dose Reduction 3D, an algorithm designed to work in both the raw data and image data spaces, the Tustin, Calif.-based company said in a press release. The system also features Toshiba’s NEMA XR 25 Dose Check Software, and incorporates Toshiba’s suite of SURETechnologies.

Justine Varieur Cadet

Related Content

What breast density status can tell us about cardiovascular risk
FDA clears AI tool that flags signs of heart disease in chest CT scans
Patients without PCPs struggle to access lung cancer screening, despite eligibility
Breast cancer rates among women in their 30s are on the rise
Singing radiologist pens song to clear up confusion about breast cancer screening recs
AI loaded onto mammography systems can flag possible cancers in real time to speed workflows

Around the web

Cardiovascular Business
Positron partners with Upbeat Cardiology Solutions to improve cardiac PET/CT access

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.